Christopher Scott

Christopher Scott has a diverse work experience in the healthcare and life sciences industry. From 2007 to 2008, they worked as a Senior QA Microbiologist at 3M, where they ensured compliance with GLP/GMP and conducted product testing. Christopher then transitioned to HistoRx, Inc., where they served as a Manager of Laboratory Operations from 2007 to 2013. In this role, they managed laboratory projects and personnel, oversaw the supply chain and inventories, and implemented barcode tracking systems. From 2013 to 2018, Christopher worked as an Associate Director of Project Management at Genoptix, Inc., where they led project teams, managed budgets, and facilitated the approval of new projects. Christopher then joined Ambry Genetics in 2018 as the Director of Project Management Organization (PMO), overseeing program and project portfolios and guiding strategic discussions with the executive team. Currently, Christopher holds the position of SVP, Operations at Renalytix, where their role focuses on eradicating kidney disease and providing clinicians with tools to assess patient risk and treatment insights.

Christopher Scott has a Master of Business Administration (M.B.A.) degree in Accounting and Operations Management from the University of Scranton. Christopher also holds a Bachelor's Degree in Biology from Stonehill College. In addition to their formal education, Christopher has obtained a Lean Six Sigma Master Black Belt (CLSSMBB) certification from Villanova University. No further information is available about their additional certifications in Agile Project Management, HTL (ASCPcm), Project Management Professional (PMP), QIHC (ASCPcm), and Six Sigma Black Belt (SSBB).